agilon health, inc. (NYSE:AGL) Receives Average Recommendation of “Reduce” from Analysts

agilon health, inc. (NYSE:AGL) has earned a consensus recommendation of “Reduce” from the twenty-one research firms that are covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have given a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $4.28.

A number of research firms have issued reports on AGL. Citigroup decreased their target price on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research report on Wednesday, November 13th. Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Evercore ISI cut their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Stifel Nicolaus lowered their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a report on Tuesday, November 12th. Finally, JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th.

Insider Activity at agilon health

In related news, Director John William Wulf acquired 45,000 shares of the stock in a transaction dated Thursday, December 5th. The stock was bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the purchase, the director now directly owns 206,133 shares of the company’s stock, valued at $449,369.94. The trade was a 27.93 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Diana Mckenzie bought 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were bought at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the transaction, the director now directly owns 51,319 shares in the company, valued at $117,007.32. This trade represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 90,000 shares of company stock worth $198,100 over the last quarter. Company insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Several hedge funds and other institutional investors have recently bought and sold shares of AGL. Citigroup Inc. grew its stake in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares during the period. AQR Capital Management LLC boosted its holdings in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares in the last quarter. JPMorgan Chase & Co. grew its stake in agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after acquiring an additional 1,083,492 shares during the period. Quantbot Technologies LP bought a new stake in shares of agilon health during the third quarter valued at approximately $1,742,000. Finally, Susquehanna Fundamental Investments LLC raised its position in shares of agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares during the period.

agilon health Price Performance

Shares of NYSE:AGL opened at $1.90 on Wednesday. The firm has a 50 day moving average of $2.18 and a 200-day moving average of $4.05. agilon health has a 12 month low of $1.50 and a 12 month high of $13.28. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $782.83 million, a PE ratio of -2.02 and a beta of 0.51.

agilon health (NYSE:AGL) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the prior year, the firm earned ($0.06) earnings per share. On average, equities research analysts predict that agilon health will post -0.52 EPS for the current fiscal year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.